Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method

References

• MullerRHRadtkeMWissingSANanostructured lipid matrices for improved microencapsulation of drugsInt J Pharm200224212121128
   Web of Science ®Google Scholar
• MullerRHKeckCMChallenges and solutions for the delivery of biotech drugs – a review of drug nanocrystal technology and lipid nanoparticlesJ Biotech200411313151170
   Web of Science ®Google Scholar
• TrottaMCavalliRTrottaCBussanoRCostaLElectrospray technique for solid lipid-based particle productionDrug Dev Ind Pharm201036443143819788405
   PubMed Web of Science ®Google Scholar
• BattagliaLGallarateMCavalliRTrottaMSolid lipid nanoparticles produced through a coacervation methodJ Microencaps20102717885
   PubMed Web of Science ®Google Scholar
• SinghSDobhalAKJainAPanditJKChakrabortySFormulation and evaluation of solid lipid nanoparticles of a water soluble drug: zidovidineChem Pharm Bull201058565065520460791
   PubMed Web of Science ®Google Scholar
• del Pozo-RodríguezADelgadoDSolinisMASolid lipid nanoparticles as potential tools for gene therapy: in vivo protein expression after intravenous administrationInt J Pharm20103851215716219819319
   PubMed Web of Science ®Google Scholar
• VarshosazJMinayianMMoazenEEnhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticlesJ Liposome Research201020211512319694503
   PubMed Web of Science ®Google Scholar
• HuLJiaHLuoZLiuCXingQImprovement of digoxin oral absorption in rabbits by incorporation into solid lipid nanoparticlesPharmazie201065211011320225654
   PubMed Web of Science ®Google Scholar
• MehnertWMaderKSolid lipid nanoparticles. Production, characterization, and applicationsAdv Drug Deliv Rev20014723165196
   Web of Science ®Google Scholar
• Quintanar-GuerreroDTamayo-EsquivelDGanem-QuintanarAAllémannEDoelkerEAdaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheresEur J Pharm Sci200526221121816046105
   PubMed Web of Science ®Google Scholar
• Tamayo-EsquivelDGanem-QuintanarAMartinezALNavarrete-RodriguezMRodriguez-RomoSQuintanar-GuerreroDEvaluation of the enhanced oral effect of omapatrilat-monolein nanoparticles prepared by the emulsification-diffusion methodJ Nanosci Nanotechnol2006691031343138
   Web of Science ®Google Scholar
• Yi FanLDa WeiCLi XiangRXiu LiZJingQSolid lipid nanoparticles for enhancing vinpocetine’s oral bioavailabilityJ Control Release20061141535916828192
   PubMed Web of Science ®Google Scholar
• NanZQinengPGuihuaHWenfangXYannaChXiuzhenHLectin-modified solid lipid nanoparticles as carriers for oral administration of insulinInt J Pharm20063271215315916962267
   PubMed Web of Science ®Google Scholar
• KovarikJMMuellerEAvan BreeJBTetzloffWKutzKReduced inter- and intra-individual variability in cyclosporine pharmacokinetics from a microemulsion formulationJ Pharm Sci19948334444468207699
   PubMed Web of Science ®Google Scholar
• MolpeceresJGuzmanMAberturasMRChaconMBergesLApplication of central composite designs to the preparation of poly-caprolactone nanoparticles by solvent displacementJ Pharm Sci19968522062138683450
   PubMed Web of Science ®Google Scholar
• TarrBDYalkowskySHEnhanced intestinal absorption of cyclosporine in rats through the reduction of emulsion droplet sizePharm Res19896140432717516
   PubMed Web of Science ®Google Scholar
• SanchezAVila-JatoJLAlonsoMJDevelopment of biodegradable microspheres and nanospheres for the controlled release of cyclosporine AInt J Pharm19939923263273
   Web of Science ®Google Scholar
• GuzmanMMolpeceresJGarciaFAberturasMRRodriguezMFormation and characterization of cyclosporine-loaded nanoparticlesJ Pharm Sci19938254985028360826
   PubMed Web of Science ®Google Scholar
• Al-AngaryAABayomiMAKhidrSHAl-MeshalMAAl-DardiriMCharacterization, stability, and in vivo targeting of liposomal formulations containing cyclosporinInt J Pharm19951142221225
   Web of Science ®Google Scholar
• MullerRHRungeSRavelliVMehnertWThunemannAFSoutoEBOral bioavailability of cyclosporine: solid lipid nanoparticles (SLN®) versus drug nanocrystalsInt J Pharm20063171828916580159
   PubMed Web of Science ®Google Scholar
• MullerRHRungeSARavelliVThunemannAFMehnertWSoutoEBCyclosporine-loaded solid lipid nanoparticles (SLN®): drug-lipid physicochemical interactions and characterization of drug incorporationEur J Pharm Biopharm200868353554417804210
   PubMed Web of Science ®Google Scholar
• VariaJKDodiyaSSSawantKKCyclosporine A loaded solid lipid nanoparticles: optimization of formulation, process variable, and characterizationCurr Drug Del2008516469
   Google Scholar
• GokceEHSandriGBonferoniMCCyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicityInt J Pharm20083641768618725276
   PubMed Web of Science ®Google Scholar
• HanafyASpahn-LangguthHVergnaultGPharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drugAdv Drug Deliv Rev200759641942617566595
   PubMed Web of Science ®Google Scholar
• ManjunathKVenkateswarluVPharmacokinetics, tissue distribution, and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administrationJ Control Release2005107221522816014318
   PubMed Web of Science ®Google Scholar
• Tamayo-EsquivelD2005Preparación de dispersiones lipídicas de talla submicrónica por medio del método de emulsificación difusiónTesis de MaestríaUniversidad Nacional Autónoma de México
   Google Scholar
• AllemannEDoelkerEGurnyRDrug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process, purification of an injectable dosage formEur J Pharm Biopharm19933911318
   Web of Science ®Google Scholar
• Quintanar-GuerreroDAllemannEDoelkerEFessiHA mechanistic study of the formation of polymer nanoparticles by the emulsion-diffusion techniqueColloid Polym Sci19972757640647
   Web of Science ®Google Scholar
• Pinon-SegundoEGanem-QuintanarAAlonso-PerezVQuintanar-GuerreroDPreparation and characterization of triclosan nanoparticles for periodontal treatmentInt J Pharm20052941221723215814226
   PubMed Web of Science ®Google Scholar
• MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
   PubMed Web of Science ®Google Scholar
• WestesenKBunjesHKochMHJPhysicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potentialJ Control Release19974823223236
   Web of Science ®Google Scholar
• HeurtaultBSaulnierPPechBPrustJEBenoitJPPhysicochemical stability of colloidal lipid particlesBiomaterials200324234283430012853260
   PubMed Web of Science ®Google Scholar
• Lechuga-BallesterosDAbdul-FattahAStevensonCLBennettDBProperties and stability of a liquid crystal form of Cyclosporine – the first reported naturally occurring peptide that exists as a thermotropic liquid crystalJ Pharm Sci20039291821183112950000
   PubMed Web of Science ®Google Scholar
• GrassoDMilardiDLa RosaCImpellizzeriGPappalardoGThe interaction of a peptide with a scrambled hydrophobic/hydrophilic sequence (Pro-Asp-Ala-Asp-Ala-His-Ala-His-Ala-His-Ala-Ala-Ala-His-Gly) (PADH) with DPPC model membranes: a DSC studyThermochim Acta2002390127378
   Web of Science ®Google Scholar
• PanickerLInfluence of the leprosy drug, dapsone, on the model membrane dipalmitoyl phosphatidylethanolamineThermochim Acta20064472123130
   Web of Science ®Google Scholar